What are you searching for?

Sign in
Breaking News

Achillion Expands with Launch of PA Office

The approximately 12,000 square-feet office space will serve as Achillion’s executive offices and clinical operations base

Achillion Pharmaceuticals announced the expansion into a second office located at 1777 Sentry Parkway West in Blue Bell, Pa. 

 
The approximately 12,000 square-feet office space will serve as Achillion’s executive offices and clinical operations base while the Company maintains its current significant research presence in New Haven, Connecticut.

“Achillion continues to expand our clinical development, clinical operations and regulatory teams as we accelerate our oral, small molecule complement inhibitor programs into late-stage development and commercialization,” said Joe Truitt, president and chief executive officer at Achillion. “We believe this additional space and proximity to talented and innovative individuals in the Philadelphia area will bolster our growing commercial capabilities as we develop treatments for patients with complement-mediated diseases.”

The new space opened for operations on January 1, 2019.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics